We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+10.19%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$10.2B
AUM Growth
+$2.04B
Cap. Flow
+$1.34B
Cap. Flow %
13.16%
Top 10 Hldgs %
16.92%
Holding
1,109
New
201
Increased
523
Reduced
236
Closed
122

Sector Composition

Rank Sector Weight
1 Technology 19.58%
2 Financials 15.64%
3 Healthcare 14.3%
4 Consumer Discretionary 12.01%
5 Industrials 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPFI icon
876
South Plains Financial
SPFI
$841M
$271K ﹤0.01%
+12,972
New +$236K
ORN icon
877
Orion Group Holdings
ORN
$514M
$270K ﹤0.01%
+52,106
New +$259K
CIVI
878
DELISTED
Civitas Resources
CIVI
$269K ﹤0.01%
+11,513
New +$228K
DSGR icon
879
Distribution Solutions Group
DSGR
$1.6B
$266K ﹤0.01%
+10,200
New +$241K
AE
880
DELISTED
Adams Resources & Energy Inc
AE
$266K ﹤0.01%
6,974
SIC
881
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
$266K ﹤0.01%
+29,583
New +$315K
KURA icon
882
Kura Oncology
KURA
$922M
$265K ﹤0.01%
19,262
-200
-1% -$2.96K
VYNE icon
883
VYNE Therapeutics
VYNE
$340K
$265K ﹤0.01%
794
-212
-21% -$70.7K
ARC
884
DELISTED
ARC Document Solutions, Inc.
ARC
$265K ﹤0.01%
190,587
+32,300
+20% +$42.1K
OTIC
885
DELISTED
Otonomy, Inc.
OTIC
$263K ﹤0.01%
68,641
-13,900
-17% -$34K
SYBX
886
DELISTED
Synlogic
SYBX
$262K ﹤0.01%
+6,765
New +$228K
NIHD
887
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$262K ﹤0.01%
+120,961
New +$234K
SKYW icon
888
Skywest
SKYW
$4.11B
$260K ﹤0.01%
4,030
LPSN icon
889
LivePerson
LPSN
$18.9M
$259K ﹤0.01%
467
OFG icon
890
OFG Bancorp
OFG
$2.21B
$259K ﹤0.01%
10,982
-8,970
-45% -$196K
TPST icon
891
Tempest Therapeutics
TPST
$14.8M
$259K ﹤0.01%
197
-2
-1% -$2.82K
VIA
892
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$257K ﹤0.01%
+5,571
New +$279K
UCFC
893
DELISTED
United Community Financial Corp
UCFC
$257K ﹤0.01%
22,040
-2,667
-11% -$29.8K
STML
894
DELISTED
Stemline Therapeutics, Inc.
STML
$254K ﹤0.01%
+23,929
New +$238K
IOSP icon
895
Innospec
IOSP
$2.09B
$253K ﹤0.01%
2,442
-122,845
-98% -$11.7M
ARGO
896
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$253K ﹤0.01%
3,845
-62,787
-94% -$4.11M
DBRG icon
897
DigitalBridge
DBRG
$2.94B
$252K ﹤0.01%
+13,268
New +$273K
OPBK icon
898
OP Bancorp
OPBK
$233M
$252K ﹤0.01%
24,327
+2,951
+14% +$29K
RRGB icon
899
Red Robin
RRGB
$134M
$252K ﹤0.01%
+7,638
New +$225K
PSB
900
DELISTED
PS Business Parks, Inc.
PSB
$252K ﹤0.01%
1,530
-11,090
-88% -$1.95M

Similar funds

Jacobs Levy Equity Management's Q4 2019 Portfolio in Review

As of Q4 2019, Jacobs Levy Equity Management held 1,109 positions worth $10.2B, up 25% from $8.15B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Jacobs Levy Equity Management deployed $1.34B of net new capital in Q4 2019, opening 201 new positions and adding to 523 existing holdings. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Qualcomm, an estimated $76.7M trimmed.

  • Jacobs Levy Equity Management's largest Q4 2019 buy was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.
  • Jacobs Levy Equity Management added most to AbbVie in Q4 2019, an estimated $57.2M increase.
  • Jacobs Levy Equity Management's biggest Q4 2019 reduction was Qualcomm, cutting an estimated $76.7M.
  • Jacobs Levy Equity Management fully exited NVR in Q4 2019, selling an estimated $49.7M.
  • Jacobs Levy Equity Management's ten largest holdings make up 17% of its $10.2B portfolio in Q4 2019.
  • Jacobs Levy Equity Management opened 201 new positions and closed 122 in Q4 2019.
  • Jacobs Levy Equity Management's portfolio value rose 25% quarter-over-quarter to $10.2B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2019, filed 14 Feb 2020.